Bottom Line: Incidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in patients who had hypophosphatemia (low blood phosphate levels).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results